Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction

Faridi, Kamil F.; Peterson, Eric D.; McCoy, Lisa A.; Thomas, Laine; Enriquez, Jonathan; Wang, Tracy Y.

doi:10.1001/jamacardio.2016.0001

Cited by 94 publications

(98 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…18 The overall mortality rate of 14.5% in our study is higher than in the regional registries: 7.8% in 2008 in the MIYAGI-AMI registry 18 and 9.6% in 2011 in the KACE registry. 19 Our finding of severity-specific mortality based on Killip class was consistent with a previous report on (10)(11)(12)(13)(14)(15)(16)(17) Ref.…”

Section: Comparison Of the Jroad-dpc With Regional Registry Studies Osupporting

confidence: 90%

The Current Status of Cardiovascular Medicine in Japan　– Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

Yasuda

Nakao

Nishimura

et al. 2016

Circ J

132

104

View full text Add to dashboard Cite

Section: Comparison Of the Jroad-dpc With Regional Registry Studies Osupporting

confidence: 90%

The Current Status of Cardiovascular Medicine in Japan　– Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

Yasuda

Nakao

Nishimura

et al. 2016

Circ J

132

104

View full text Add to dashboard Cite

“…Supporting this finding, visiting with a cardiologist after MI discharge has been associated with 10–20% higher adherence to high-dose statin therapy at 6 months as well as similarly increased rates of persistence at 2 years [34]. Timing may be important in light of the observation of an association between patients who visit a provider within 6 weeks of MI discharge and a 5–10% higher (in absolute terms) adherence to post-MI therapies both short and long term [42•]. It merits mentioning that there are data that provider visits need not solely be with physicians.…”

Section: Health Team and System-related Factorsmentioning

confidence: 99%

Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System

Levy¹,

Huang

et al. 2018

Curr Atheroscler Rep

View full text Add to dashboard Cite

Purpose of Review Non-adherence to medications for the secondary prevention of myocardial infarction (MI) is a major contributor to morbidity and mortality in these patients. This review describes recent advances in promoting adherence to therapies for coronary artery disease (CAD). Recent Findings Two large randomized controlled trials to “incentivize” adherence were somewhat disappointing; neither financial incentives nor “peer pressure” successfully increased rates of adherence in the post-MI population. Patient education and provider engagement appear to be critical aspects of improving adherence to CAD therapies, where the provider is a physician, pharmacist, or nurse and follow-up is performed in person or by telephone. Fixed-dose combinations of CAD medications, formulated as a so-called “polypill,” have shown some early efficacy in increasing adherence. Technological advances that automate monitoring and/or encouragement of adherence are promising but seem universally dependent on patient engagement. For example, medication reminders via text message perform better if patients are required to respond. Multifaceted interventions, in which these and other interventions are combined together, appear to be most effective. Summary There are several available types of proven interventions through which providers, and the health system at large, can advance patient adherence to CAD therapies. No single intervention to promote adherence will be successful in all patients. Further study of multifaceted interventions and the interactions between different interventions will be important to advancing the field. The goal is a learning healthcare system in which a network of interventions responds and adapts to patients’ needs over time.

show abstract

“…Recent evidence suggests that improved hospital to home care transitions can increase medication adherence in the post-hospitalization period. 14 …”

Section: Introductionmentioning

confidence: 99%

Inhaled Corticosteroid Claims and Outpatient Visits After Hospitalization for Asthma Among Commercially Insured Children

Andrews

Bundy

Simpson

et al. 2017

Academic Pediatrics

View full text Add to dashboard Cite

Objective Determine rates of inhaled corticosteroid (ICS) claims and outpatient follow-up after asthma hospitalization among commercially insured children. Methods We conducted a retrospective cohort analysis of children hospitalized for asthma using 2013 national Truven® MarketScan data. Covariates included age, sex, region, length of stay and having an ICS claim within 35 days before hospitalization. Outcome variables were a claim for any ICS-containing medication and outpatient visit within 30 days after discharge. Multivariable analysis used logistic regression. Results 5471 children age 2–17 were included. 61% were male, mean age was 6.8 years. 41% had a claim for an ICS and 76% had an outpatient visit within 30 days after hospital discharge. In multivariable analysis, children who had an ICS claim within 35 days before the hospitalization were more likely to have an ICS claim within 30 days after discharge (RR 1.3 (1.2–1.5)). The strongest predictor of an ICS claim within 30 days after discharge was attendance at an outpatient appointment (RR 1.4 (1.3–1.6)). Children age 2–6 were more likely to attend an outpatient appointment (RR 1.1 95% CI 1.1–1.2). Children with an ICS claim before admission were also more likely to attend an outpatient appointment (RR 1.1 95% CI 1.004–1.1). Conclusions In this national sample of commercially insured children with asthma, rates of ICS claims after hospitalization are low despite high rates of outpatient visits. Both inpatient and outpatient physicians must play a role in increasing ICS adherence in this high risk population of children with asthma.

show abstract

Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction

Abstract: Delayed outpatient follow-up beyond the first 6 weeks after AMI is associated with worse short-term and long-term patient medication adherence. These data support the concept that medication adherence is modifiable via improved care transitions.

Cited by 94 publications

References 33 publications

The Current Status of Cardiovascular Medicine in Japan　– Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

The Current Status of Cardiovascular Medicine in Japan　– Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System

Inhaled Corticosteroid Claims and Outpatient Visits After Hospitalization for Asthma Among Commercially Insured Children

Contact Info

Product

Resources

About

Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction

Abstract: Delayed outpatient follow-up beyond the first 6 weeks after AMI is associated with worse short-term and long-term patient medication adherence. These data support the concept that medication adherence is modifiable via improved care transitions.

Cited by 94 publications

References 33 publications

The Current Status of Cardiovascular Medicine in Japan – Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

The Current Status of Cardiovascular Medicine in Japan – Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System

Inhaled Corticosteroid Claims and Outpatient Visits After Hospitalization for Asthma Among Commercially Insured Children

Contact Info

Product

Resources

About

The Current Status of Cardiovascular Medicine in Japan　– Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –

The Current Status of Cardiovascular Medicine in Japan　– Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC –